Skip to main content
. Author manuscript; available in PMC: 2021 Jul 2.
Published in final edited form as: Eur Urol Oncol. 2018 Jun 13;1(5):364–377. doi: 10.1016/j.euo.2018.04.015

Table 5 –

Association of clinical factors with overall survival in the preoperative renal cell carcinoma population (n = 175) a

Factor N [n deaths] Univariate
Multivariate
HR (95% CI) p value HR (95% CI) p value
Age 175 1.23 (0.76–1.98) 0.391
Tumor size 175 2.53 (1.77–3.62) <0.001 1.13 (0.56–2.29) 0.723
Tumor grade
 Grade 2 or low 50 [2] 1
 Grade >2 or high 90 [14] 8.42 (1.11–6.41) 0.039
 Not available 35
TNM stage
 I or II 101 [3] 1
 III or IV 74 [16] 11.67 (2.68–5.08) 0.001
Nephrectomy type
 Partial 113 [2] 1
 Radical 62 [17] 34.8 (4.6–261.6) <0.001
Surgical margins
 Negative 170 [16] 1
 Positive 5 [3] 5.18 (2.12–12.6) <0.001 4.06 (0.75–22) 0.105
SSIGN score 118 3.37 (2.21–5.13) <0.001 5.04 (2.53–10) <0.001
New GAG score 175 1.25 (0.97–1.62) 0.080
6s CS 175 0.35 (0.14–0.91) 0.032
6s/(4s + 6s) CS 175 0.62 (0.34–1.14) 0.125
CStot 175 1.34 (1.11–1.62) 0.002 1.51 (1.19–1.93) <0.001
CS charge 175 0.44 (0.24–0.80) 0.008
log2(0sNs+0sHS) 175 0.80 (0.52–1.22) 0.293

HR = hazard ratio; CI = confidence interval; GAG = glycosaminoglycan; SSIGN = Stage, Size, Grade, and Necrosis; CS = chondroitin sulfate; HS = heparan sulfate.

a

In multivariate analysis, patients with missing data for any of the selected covariates were omitted (n = 57). Continuous variables were centered to the mean and scaled to the standard deviation.